A critical review of pharmacotherapy for youth with anxiety disorders: things are not as they seem (Q41749525)

8 October 2017

1 reference

title

A critical review of pharmacotherapy for youth with anxiety disorders: things are not as they seem (English)

1 reference

8 October 2017

0 references

1 reference

Kearney CA

1

1 reference

8 October 2017

Silverman WK

series ordinal

2

1 reference

8 October 2017

publication date

1 March 1998

1 reference

Journal of Anxiety Disorders

8 October 2017

published in

1 reference

8 October 2017

volume

12

1 reference

8 October 2017

issue

2

1 reference

8 October 2017

page(s)

83-102

1 reference

Buspirone augmentation of fluoxetine in a depressed child with obsessive-compulsive disorder

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Current knowledge of medications for the treatment of childhood anxiety disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Three cases of panic disorder with agoraphobia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

School phobia: a therapeutic trial with clomipramine and short-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Comparative studies of pharmacotherapy for school refusal

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Fluoxetine for childhood anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Panic disorder in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Elective mutism as a variant of social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

An open-label trial of fluoxetine for obsessive-compulsive disorder in Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

The treatment of behavior disorders in children with benadryl.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

The effectiveness of psychotherapy alone and in confunction with perphenazine or placebo in the treatment of neurotic and hyperkinetic children

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Drug Use in Psychiatric Disorders of Children

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Treatment of childhood depression with antidepressant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Panic disorder on a child psychiatric consultation service

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Clonazepam in childhood anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Acceptability of alternative treatments for school refusal: evaluations by students, caregivers, and professionals

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Neurologic presentations of panic disorder in childhood and adolescence.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Expressions of the hyperventilation syndrome in childhood: studies in management, including an evaluation of the effectiveness of propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Anxiety disorders in mid-adolescence: a community sample

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Imipramine treatment of children with separation anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Use of buspirone in an adolescent with overanxious disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Fluoxetine for adolescents with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Tourette syndrome, pimozide, and school phobia: the neuroleptic separation anxiety syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Psychoactive drugs in the treatment of emotionally disturbed children: Haloperidol and diazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol-driven treatment package

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

DSM-III disorders in a large sample of adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Imipramine treatment of school phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Developmental issues in psychotherapy research.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Alprazolam effects in children with anxiety disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Clinical criteria for psychiatric diagnosis and DSM-III

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Panic attack syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

The psychiatric nomenclature. Reasons for diagnostic disagreement.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Child and adolescent psychotherapy outcomes in experiments versus clinics: why the disparity?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Definitions of panic attacks and panic disorder in the DSM-IV: implications for research

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

Diagnosis, assessment, and treatment of internalizing problems in children: the role of longitudinal data

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

U.S. mental health policy. Proactive evolution in the midst of health care reform

1 reference

https://api.crossref.org/works/10.1016%2FS0887-6185%2898%2900005-X

7 January 2021

10.1016/S0887-6185(98)00005-X

Identifiers

DOI

1 reference

release_3x7kahbdebdxbmo3blwx6yaivy

8 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3x7kahbdebdxbmo3blwx6yaivy

24 November 2022

mapped directly with Wikidata item

1 reference